Cite
APA Citation
Bellmann, L., Cappellano, G., Schachtl‐Riess, J. F., Prokopi, A., Seretis, A., Ortner, D., Tripp, C. H., Brinckerhoff, C. E., Mullins, D. W., & Stoitzner, P. (2020). a TLR7 agonist strengthens T and NK cell function during BRAF‐targeted therapy in a preclinical melanoma model. International journal of cancer, 146(5), 1409–1420. http://access.bl.uk/ark:/81055/vdc_100099158589.0x000058